| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
1999-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b69d740c901015f7b51a509373545b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f8720b7981e95a20d533fc7bf066ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69bfa7b272f633db418fad9e23a0a90e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c0223758a831d433856154590ce139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_833554f3c69c3cc63a93c8bd67f1f449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba44f26b02ce58d940b40b845cd667f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3c66dbd72544f68b880815b462b2da9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c3363f79258b947c5d548b5bcc48dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4b55a6aa671ce3012788da16536daae |
| publicationDate |
2000-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2000169393-A |
| titleOfInvention |
Drug containing anti-Fas antibody |
| abstract |
PROBLEM TO BE SOLVED: To provide human and mouse Fas useful as a therapeutic agent for a disease caused by the above Fas / Fas ligand system. Provided is a novel pharmaceutical composition containing an anti-Fas antibody that also binds to s as an active ingredient. SOLUTION: Abnormality of Fas / Fas ligand system containing as an active ingredient a molecule characterized by having an antigen-binding region specific to an epitope conserved between primate and non-primate animal Fas. An agent for preventing or treating a disease caused by. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015145394-A |
| priorityDate |
1998-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |